Skip to content

Tailored Plan Clinical Coverage Policies

Tailored Plan Clinical Coverage Policies

‘I am a provider’ - Partners Tailored Plan
Home » Tailored Plan » Providers » Manuals, Forms and Policies » Tailored Plan Clinical Coverage Policies

Partners is committed to the care of the members and recipients we serve. Clinical coverage policies are the primary criteria used to assist in administering health plan benefits. They include but are not limited to policies relating to evolving medical technologies and procedures, as well as pharmacy policies. Clinical policies help identify whether services are medically necessary.

As part of the Partners Benefit Plan, below you will find a list of Medicaid and Clinical Coverage Policies by which Partners has adopted Clinical Criteria to make Medical Necessity Decisions. The full policies can be found on the NCDHHS Program Specific Clinical Coverage Policies page.

For more information, or if you have questions about clinical coverage policies, please email UMQuestions@PartnersBHM.org.

North Carolina Medicaid Program Specific Clinical Coverage Policies

Allergies

  • 1N-1, Allergy Testing
  • 1N-2, Allergy Immunotherapy

Ambulance

  • 15, Ambulance Services
    • For guidance in reference to fixed-wing transport, refer to the Carolina Complete Health policy for Air Ambulance

Anesthesia

  • 1L-1, Anesthesia Services
  • 1L-2, Moderate (Conscious) Sedation, AKA Procedural Sedation and Analgesia (PSA)

Auditory Implants External Parts

  • 13A, Cochlear and Auditory Brainstem Implant External Parts Replacement and Repair
  • 13B, Soft Band and Implantable Bone Conduction Hearing Aid External Parts Replacement and Repair

Behavioral Health

  • 8A, Enhanced Mental Health and Substance Abuse Services
  • 8A-1, Assertive Community Treatment (ACT) Program
  • 8A-2, Facility-Based Crisis Service for Children and Adolescents
  • 8A-5, Diagnostic Assessment
  • 8A-6, Community Support Team (CST)
  • 8A-7, Ambulatory Withdrawal Management (WM) without Extended On-Site Monitoring
  • 8A-8, Ambulatory Withdrawal Management with Extended On-Site Monitoring
  • 8A-9, Treatment Program Service Opioid
  • 8A-10, Clinically Managed Residential Withdrawal Management Services
  • 8A-11, Medically Monitored Inpatient Withdrawal Management Service
  • 8A-12, Substance Abuse Intensive Outpatient Program (SAIOP)
  • 8A-13, Substance Abuse Comprehensive Outpatient Treatment (SACOT)
  • 8B, Inpatient Behavioral Health Services
  • 8C, Outpatient Behavioral Health Services Provided by Direct-Enrolled Providers
  • 8D-1, Psychiatric Residential Treatment Facilities for Children under the Age of 21
  • 8D-2, Residential Treatment Services
  • 8D-3, Clinically Managed Low-Intensity Residential Treatment Services
  • 8D-4, Clinically Managed Population Clinical Specific High-Intensity Residential Program
  • 8D-5, Clinically Managed Residential Services
  • 8D-6, Medically Monitored Intensive Inpatient Services
  • 8E, Intermediate Care Facilities for Individuals with Intellectual Disabilities
  • 8F, Research-Based Behavioral Health Treatment (RB-BHT) For Autism Spectrum Disorder (ASD)
  • 8G, Peer Support Services
  • 8H-1, 1915(i) Supported Employment for I/DD and TBI
  • 8H-2, 1915(i) Individual Placement & Support (IPS) for Mental Health & Substance Use
  • 8H-3, 1915(i) Individual and Transitional Support (ITS)
  • 8H-4, 1915(i) Respite
  • 8H-5, Community Living and Supports
  • 8H-6, 1915(i) Community Transition
  • 8I, Psychological Services in Health Departments and School-Based Health Centers Sponsored by Health Departments to the under-21 Population
  • 8L, Mental Health/Substance Abuse Targeted Case Management
  • 8P, North Carolina Innovations

Burn Treatments & Skin Substitutes

  • 1G-1, Burn Treatment
  • 1G-2, Skin Substitutes

Cardiac Procedures

  • 1R-1, Phase II Outpatient Cardiac Rehabilitation Programs
  • 1R-4, Electrocardiography, Echocardiography, and Intravascular Ultrasound
    • The following procedures do require prior authorization and should be obtained through Evolent: Transthoracic Echocardiography (TTE); Transesophageal Echocardiography (TEE); Stress Echocardiography.
    • Also refer to the Carolina Complete Health policy for Holter Monitors

Chiropractic Services

  • 1F, Chiropractic Services

Community-Based Services

Dietary Evaluation and Counseling

  • 1-I, Dietary Evaluation and Counseling and Medical Lactation Services

Facility Services

  • 2A-1, Acute Inpatient Hospital Services
  • 2A-2, Long Term Care Hospital Services
  • 2A-3, Out-of-State Services
  • 2B-1, Nursing Facilities
  • 2B-2, Geropsychiatric Units in Nursing Facilities

Genetic Testing

The following procedures require prior authorization, which should be obtained through EviCore:

Hearing Aid Services

  • 7, Hearing Aid Services

Laboratory Services

  • 1S-1, Genotyping and Phenotyping for HIV Drug Resistance Testing
  • 1S-2, HIV Tropism Assay
  • 1S-3, Laboratory Services
  • 1S-8, Drug Testing for Opioid Treatment and Controlled Substance Monitoring
  • 1S-9, Genetic Testing for Diagnosis and Treatment
    • Prior authorization is required for all genetic testing.
  • 1S-10, Genetic Testing for Carrier and Prenatal
    • Prior authorization is required for all genetic testing.
  • 1S-13, Cell and Gene Therapies

Maternal Support Services (Baby Love)

  • 1M-2, Childbirth Education
  • 1M-3, Health and Behavior Intervention
  • 1M-4, Home Visit for Newborn Care and Assessment
  • 1M-5, Home Visit for Postnatal Assessment and Follow-up Care
  • 1M-6, Maternal Care Skilled Nurse Home Visit

Medical Equipment

  • 5A-1, Physical Rehabilitation Equipment and Supplies
  • 5A-2, Respiratory Equipment and Supplies
    • Prior approval is required prior to the initiation of oxygen therapy and for continuation of active oxygen therapy on at least an annual basis.
  • 5A-3, Nursing Equipment and Supplies
  • 5B, Orthotics & Prosthetics

Obstetrics & Gynecology

  • 1E-1, Hysterectomy
  • 1E-2, Therapeutic and Non-therapeutic Abortions
  • 1E-3, Sterilization Procedures
  • 1E-4, Fetal Surveillance
  • 1E-5, Obstetrics
  • 1E-6, Pregnancy Management Program
  • 1E-7, Family Planning Services

Ophthalmological Services

  • 1T-1, General Ophthalmological Services
  • 1T-2, Special Ophthalmological Services

Pharmacy Services

Clinical Coverage Criteria and Prior Approval request forms

Preferred Drug List (PDL)

  • 9, Outpatient Pharmacy Program
  • 9A, Over-The-Counter Products
  • 9B, Hemophilia Specialty Pharmacy Program
  • 9D, Off Label Antipsychotic Safety Monitoring in Beneficiaries Through Age 17
  • 9E, Off Label Antipsychotic Safety Monitoring in Beneficiaries 18 and Older

Physician-Administered Drug Program

1B Physician Administered Drug Program (PADP)

Physician Clinical Coverage Policies

  • 1A-2, Preventive Medicine Annual Health Assessment
  • 1A-3, Noninvasive Pulse Oximetry
  • 1A-4, Cochlear and Auditory Brainstem Implants
  • 1A-5, Child Medical Evaluation and Medical Team Conference for Child Maltreatment
  • 1A-6, Invasive Electrical Bone Growth Stimulation
  • 1A-7, Neonatal and Pediatric Critical and Intensive Care Services
  • 1A-8, Hyperbaric Oxygenation Therapy
  • 1A-9, Blepharoplasty/Blepharoptosis (Eyelid Repair)
  • 1A-11, Extracorporeal Shock Wave Lithotripsy
  • 1A-12, Breast Surgeries
  • 1A-13, Ocular Photodynamic Therapy
  • 1A-14, Surgery for Ambiguous Genitalia
  • 1A-15, Surgery for Clinically Severe or Morbid Obesity
  • 1A-16, Surgery of the Lingual Frenulum
  • 1A-17, Stereotactic Pallidotomy
  • 1A-19, Transcranial Doppler Studies
  • 1A-20, Sleep Studies and Polysomnography Services
  • 1A-21 Endovascular Repair of Aortic Aneurysm
  • 1A-22, Medically Necessary Circumcision
  • 1A-23, Physician Fluoride Varnish Services
  • 1A-24, Diabetes Outpatient Self-Management Education
  • 1A-25, Spinal Cord Stimulation
  • 1A-26, Deep Brain Stimulation
  • 1A-27, Electrodiagnostic Studies
  • 1A-28, Visual Evoked Potential (VEP)
  • 1A-30 Spinal Surgeries
  • 1A-31, Wireless Capsule Endoscopy
  • 1A-32, Tympanometry and Acoustic Reflex Testing
  • 1A-33, Vagus Nerve Stimulation for the Treatment of Seizures
  • 1A-34, Dialysis Services
  • 1A-36, Implantable Bone Conduction Hearing Aids (BAHA)
  • 1A-38, Special Services: After Hours
  • 1A-39, Routine Patient Costs Furnished in Connection with Participation in Qualifying Clinical Trials
  • 1A-40, Fecal Microbiota Transplantation
    • Prior authorization is required for all transplant procedures.
  • 1A-42, Balloon Ostial Dilation

Podiatry

  • 1C-1, Podiatry Services
  • 1C-2, Medically Necessary Routine Foot Care

Radiology

  • 1K-1, Breast Imaging Procedures
    • MRI breast procedures do require prior authorization and should be obtained through Evolent.
  • 1K-2, Bone Mass Measurement
  • 1K-6 Radiation Oncology

Reconstructive Surgery

  • 1-O-1, Reconstructive and Cosmetic Surgery
  • 1-O-2, Craniofacial Surgery
  • 1-O-3, Keloid Excision and Scar Revision
  • 1-O-5, Rhinoplasty and/or Septorhinoplasty

Rural Health Clinics, FQHC and Health Departments. (RHC, FQHC, Health Depts)

  • 1D-1, Refugee Health Assessments Provided in Health Departments
  • 1D-2, Sexually Transmitted Disease Treatment Provided in Health Departments
  • 1D-3, Tuberculosis Control and Treatment Provided in Health Departments
  • 1D-4, Core Services Provided in Federally Qualified Health Centers and Rural Health Clinics

Solid Organ Transplants

Prior authorization is required for all transplant procedures.

  • 11B-1, Lung Transplantation
  • 11B-2, Heart Transplantation
  • 11B-3, Islet Cell Transplantation
  • 11B-4, Kidney (Renal) Transplantation
  • 11B-5, Liver Transplantation
  • 11B-6, Heart/Lung Transplantation
  • 11B-7, Pancreas Transplant
  • 11B-8, Small Bowel and Small Bowel/Liver and Multivisceral Transplants
  • 11B-9, Thymus Tissue Implantation

Specialized Therapies

Stem Cell Transplants

Prior authorization is required for all transplant procedures.

  • 11A-1, Hematopoietic Stem-Cell Transplantation for Acute Lymphoblastic Leukemia (ALL)
  • 11A-2, Hematopoietic Stem-Cell Transplant for Acute Myeloid Leukemia
  • 11A-3, Hematopoietic Stem-Cell Transplantation for Chronic Myelogenous Leukemia
  • 11A-5, Allogeneic Hematopoietic Transplant for Genetic Diseases and Acquired Anemias
  • 11A-6, Hematopoietic Stem-Cell Transplantation in the Treatment of Germ Cell Tumors
  • 11A-7, Hematopoietic Stem-Cell Transplantation for Hodgkin Lymphoma
  • 11A-8, Hematopoietic Stem-Cell Transplantation For Multiple Myeloma and Primary Amyloidosis
  • 11A-9, Allogeneic Stem-Cell Transplantation for Myelodysplastic Syndromes & Myeloproliferative Neoplasms
  • 11A-10, Hematopoietic Stem-Cell Transplantation (HSCT) for Central Nervous System (CNS) Embryonal Tumors & Ependymoma
  • 11A-11, Hematopoietic Stem-Cell Transplant for Non-Hodgkin’s Lymphoma
  • 11A-14, Placental and Umbilical Cord Blood as a Source of Stem Cells
  • 11A-15, Hematopoietic Stem-Cell Transplantation for Solid Tumors of Childhood
  • 11A-16, Hematopoietic Stem-Cell Transplantation for Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)
  • 11A-17, CAR T-Cell Therapy

Targeted Case Management

  • 12B, Human Immunodeficiency Virus (HIV) Case Management

Telehealth

Ventricular Assist Device

Vision Services

Policies Adopted from Carolina Complete Health

Air Ambulance

Bariatric Surgery

Breast Surgeries

Bronchial Thermoplasty

Cardiac Biomarker Testing

CAR T-Cell Therapy

Diaphragmatic/Phrenic Nerve Stimulation

Digital EEG Spike Analysis

Disc Decompression Procedures

Discography

Drugs of Abuse: Definitive Testing

EEG in the Evaluation of Headache

Electric Tumor Treating Fields (Optune)

Endometrial Ablation

Evoked Potential Testing

Excimer Laser Therapy for Skin Conditions

Experimental Technologies

Extended Ophthalmoscopy

External Ocular Photography

Facility-based Sleep Studies for Obstructive Sleep Apnea

Fecal Incontinence Treatments NC.CP.MP.137

Fetal Surgery in Utero for Prenatally Diagnosed Malformations NC.CP.MP.129

Fluorescein Angiography

Gastric Electrical Stimulation

Gonioscopy

Heart-Lung Transplant

  • Prior authorization is required for all transplant procedures.

Helicobacter Pylori Serology Testing

Holter Monitors

Homocysteine Testing

Hyperhidrosis Treatments

Implantable Intrathecal or Epidural Pain Pump

Implantable Wireless Pulmonary Artery Pressure Monitoring

Intestinal and Multivisceral Transplant

  • Prior authorization is required for all transplant procedures.

Intradiscal Steroid Injections for Pain Management

IV Moderate Sedation, IV Deep Sedation, and General Anesthesia for Dental Procedures

Lab Testing – Concert Genetics Infectious Disease: Respiratory Testing

Lab Testing – Concert Genetics Infectious Disease: Multisystem Testing

Lab Testing – Concert Genetics Infection Disease: Dermatologic Testing

Lab Testing – Concert Genetics Infectious Disease: Primary Care Preventative Testing

Lab Testing – Concert Genetics Infectious Disease: Vector Borne and Tropical Disease Testing

Lab Testing – Concert Genetics Infectious Disease: Genitourinary Testing

Laser Therapy for Skin Conditions

Lysis of Epidural Lesions

Measurement of Serum 1,25-dihydroxyvitamin D (aka Vitamin D)

Mechanical Stretching Devices for Joint Stiffness and Contracture

Neonatal Abstinence Syndrome Guidelines

Neonatal Sepsis Management

Nerve Blocks and Neurolysis for Pain Management

NICU Apnea Bradycardia Guidelines

NICU Discharge Guidelines

Orthognathic Surgery

Osteogenic Stimulation NC.CP.MP.194

Pancreas Transplantation

  • Prior authorization is required for all transplant procedures.

Panniculectomy

Pediatric Kidney Transplant

  • Prior authorization is required for all transplant procedures.

Phototherapy for Neonatal Hyperbilirubinemia

Posterior Tibial Nerve Stimulation for Voiding Dysfunction

Proton and Neutron Beam Therapies

Sclerotherapy and Chemical Endovenous Ablation for Varicose Veins and Other Symptomatic Venous Disorders

Selective Dorsal Rhizotomy for Spasticity in Cerebral Palsy

Spinal Cord, Peripheral Nerve, and Percutaneous Electrical Nerve Stimulation

Therapeutic Utilization of Inhaled Nitric Oxide

Thyroid Hormones and Insulin Testing in Pediatrics

Total Parenteral Nutrition and Intradialytic Parenteral Nutrition

Trigger Point Injections for Pain Management

Urinary Incontinence Devices and Treatments

Urodynamic Testing

Vagus Nerve Stimulation for the Treatment of Seizures

Ventricular Assist Devices

Visual Field Testing

25-hydroxyvitamin D Testing in Children and Adolescents

‘In Lieu of’ Services

Partners can develop and present ideas for new services to the NC Division of Health Benefits (DHB) for approval. These services are covered through “Alternative” or “in lieu of” service definitions. These services are not available in the traditional benefit plan and are different from 1915(i) services. DHB can approve these new services for reimbursement under Medicaid and, in some cases, with State funding.

Partners’ In Lieu of Services Policy

In Lieu of Service Definitions: